Showing results (21-30 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|July 18, 2000
Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase orthologM Guida, M Riedy, D Lee, et al.Pharmacogenetics|July 18, 2000
Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type IIN M Makridakis, E di Salle, J K ReichardtPharmacogenetics|July 18, 2000
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotypeV H Brophy, G P Jarvik, R J Richter, et al.Pharmacogenetics|July 18, 2000
Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotypeR J Delfino, C Smith, J G West, et al.Pharmacogenetics|January 5, 2002
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphineJörn Lötsch, Carsten Skarke, Sabine Grösch, et al.Pharmacogenetics|January 5, 2002
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymesZhen-Hua Xu, Robert R Freimuth, Bruce Eckloff, et al.Pharmacogenetics|January 5, 2002
Implications of circadian gene expression in kidney, liver and the effects of fasting on pharmacogenomic studiesYasuhiro Kita, Masahide Shiozawa, Weihong Jin, et al.Pharmacogenetics|December 12, 2001
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoinR S Kidd, T B Curry, S Gallagher, et al.Pharmacogenetics|December 12, 2001
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphismG Sofowora, V Dishy, H G Xie, et al.Pharmacogenetics|July 27, 2002
beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung diseaseRainer Büscher, Katrin Jennifer Eilmes, Hartmut Grasemann, et al.Pageof 83